MeSH Review:
Cerebral Infarction
DeCarli,
Reed,
Wolf,
Noya,
Dávalos,
Castillo,
Serena,
Blanco,
Carmelli,
Michiaki Kubo,
Jun Hata,
Toshiharu Ninomiya,
Koichi Matsuda,
Koji Yonemoto,
Toshiaki Nakano,
Tomonaga Matsushita,
Keiko Yamazaki,
Yozo Ohnishi,
Susumu Saito,
Takanari Kitazono,
Setsuro Ibayashi,
Katsuo Sueishi,
Mitsuo Iida,
Yusuke Nakamura,
Yutaka Kiyohara,
Serena,
Lizasoain,
Moro,
Dávalos,
Castillo,
Leira,
Swan,
Miller,
- Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Ezekowitz, M.D., Bridgers, S.L., James, K.E., Carliner, N.H., Colling, C.L., Gornick, C.C., Krause-Steinrauf, H., Kurtzke, J.F., Nazarian, S.M., Radford, M.J. N. Engl. J. Med. (1992)
- Intraoperative cerebral infarction after desmopressin administration in infant with end-stage renal disease. Grunwald, Z., Sather, S.D. Lancet (1995)
- Activated protein C resistance in cases of cerebral infarction. Forsyth, P.D., Dolan, G. Lancet (1995)
- The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Castillo, J., Moro, M.A., Blanco, M., Leira, R., Serena, J., Lizasoain, I., Dávalos, A. Ann. Neurol. (2003)
- Intracerebral hemorrhage versus infarction: stroke severity, risk factors, and prognosis. Jørgensen, H.S., Nakayama, H., Raaschou, H.O., Olsen, T.S. Ann. Neurol. (1995)
- Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. Peress, N.S., Perillo, E. J. Neuropathol. Exp. Neurol. (1995)
- When do strokes cause dementia? Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Foster, N.L., Hickenbottom, S.L. Arch. Neurol. (1999)
- Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. DeCarli, C., Miller, B.L., Swan, G.E., Reed, T., Wolf, P.A., Carmelli, D. Arch. Neurol. (2001)
- Inosine reduces ischemic brain injury in rats. Shen, H., Chen, G.J., Harvey, B.K., Bickford, P.C., Wang, Y. Stroke (2005)
- Demonstration of ganglioside GD3 in human reactive astrocytes. Kawai, K., Watarai, S., Takahashi, H., Ishizu, H., Fukai, K., Tanabe, Y., Yokota, O., Kuroda, S. Psychiatry and clinical neurosciences. (1999)
- Prostacyclin in cerebral infarction. Martin, J.F., Hamdy, N., Nicholl, J., Lewtas, N., Bergvall, U., Owen, P., Syder, D., Middlebrook, A. N. Engl. J. Med. (1985)
- Neuroprotection mediated by changes in the endothelial actin cytoskeleton. Laufs, U., Endres, M., Stagliano, N., Amin-Hanjani, S., Chui, D.S., Yang, S.X., Simoncini, T., Yamada, M., Rabkin, E., Allen, P.G., Huang, P.L., Böhm, M., Schoen, F.J., Moskowitz, M.A., Liao, J.K. J. Clin. Invest. (2000)
- Multiple subcortical infarction: CADASIL in context. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. Broe, G.A., Bennett, H.P. Lancet (1995)
- Cerebral infarction, cerebral haemorrhage, and ABO blood-groups. Larsen, S., Anthonisen, B., Marquardsen, J. Lancet (1977)
- Letter: Glycerol v. dexamethasone in acute cerebral infarction. Silverstone, P.I., McIntosh, A.S. Lancet (1975)
- Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Okajima, K., Abe, H., Maeda, S., Motomura, M., Tsujihata, M., Nagataki, S., Okabe, H., Takatsuki, K. Blood (1993)
- Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Kushner, M., Nencini, P., Reivich, M., Rango, M., Jamieson, D., Fazekas, F., Zimmerman, R., Chawluk, J., Alavi, A., Alves, W. Ann. Neurol. (1990)
- Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neonatal rat. Hattori, H., Wasterlain, C.G. Ann. Neurol. (1990)
- Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction. Meyer, J.S., Itoh, Y., Okamoto, S., Welch, K.M., Mathew, N.T., Ott, E.O., Sakaki, S., Miyakawa, Y., Chabi, E., Ericsson, A.D. Circulation (1975)
- Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Joseph, R., D'Andrea, G., Oster, S.B., Welch, K.M. Stroke (1989)
- Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Salonen, J.T., Puska, P., Tuomilehto, J., Homan, K. Stroke (1982)
- Effects of agents used in the pharmacotherapy of cerebrovascular disease on the oxygen consumption of isolated cerebral mitochondria. Nowicki, J.P., MacKenzie, E.T., Spinnewyn, B. J. Cereb. Blood Flow Metab. (1982)
- Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Couderc, R., Mahieux, F., Bailleul, S., Fenelon, G., Mary, R., Fermanian, J. Stroke (1993)
- Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple slcerosis. Bashir, R.M., Whitaker, J.N. Ann. Neurol. (1980)
- Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Griffey, R.H., Brown, M.S., Bankhurst, A.D., Sibbitt, R.R., Sibbitt, W.L. Arthritis Rheum. (1990)
- Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. De Keyser, J., Wilczak, N., Leta, R., Streetland, C. Neurology (1999)
- Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Xia, C.F., Yin, H., Yao, Y.Y., Borlongan, C.V., Chao, L., Chao, J. Hum. Gene Ther. (2006)
- Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Umemura, K., Wada, K., Uematsu, T., Nakashima, M. Stroke (1993)
- Increased plasma endothelin-1 in acute ischemic stroke. Ziv, I., Fleminger, G., Djaldetti, R., Achiron, A., Melamed, E., Sokolovsky, M. Stroke (1992)
- Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Harvey, B.K., Hoffer, B.J., Wang, Y. Pharmacol. Ther. (2005)
- Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Loddick, S.A., Rothwell, N.J. J. Cereb. Blood Flow Metab. (1996)
- Role of cyclooxygenase-2 in the development of bladder overactivity after cerebral infarction in the rat. Yotsuyanagi, S., Yokoyama, O., Komatsu, K., Kodama, K., Nagasaka, Y., Namiki, M. J. Urol. (2005)
- A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Kubo, M., Hata, J., Ninomiya, T., Matsuda, K., Yonemoto, K., Nakano, T., Matsushita, T., Yamazaki, K., Ohnishi, Y., Saito, S., Kitazono, T., Ibayashi, S., Sueishi, K., Iida, M., Nakamura, Y., Kiyohara, Y. Nat. Genet. (2007)
- Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Fletcher, A.P., Alkjaersig, N., Davies, A., Lewis, M., Brooks, J., Hardin, W., Landau, W., Raichle, M.E. Stroke (1976)
- CT enhancement after prolonged high-dose contrast infusion in the early stage of cerebral infarction. Ito, U., Tomita, H., Kito, K., Ueki, Y., Inaba, Y. Stroke (1986)
- Hemorrhagic complications of thrombolytic therapy in experimental stroke. Slivka, A., Pulsinelli, W. Stroke (1987)
- Duration of glutamate release after acute ischemic stroke. Dávalos, A., Castillo, J., Serena, J., Noya, M. Stroke (1997)
- Free protein S deficiency in acute ischemic stroke. A case-control study. Mayer, S.A., Sacco, R.L., Hurlet-Jensen, A., Shi, T., Mohr, J.P. Stroke (1993)